Last updated: March 14, 2026
What does patent LTPA2021502 cover regarding its scope and claims?
LTPA2021502 is a Lithuanian pharmaceutical patent primarily focused on a novel drug formulation or compound. The patent’s claims define protection scope, which typically encompasses chemical entities, formulations, methods of use, and manufacturing processes.
Scope and Claims Overview
- Chemical Composition Claims: The patent claims a specific chemical molecule or a set of structurally related compounds. Claims specify the structure, substitution pattern, or experimental variants that meet the patent's criteria.
- Method of Use Claims: Includes indications for treating certain diseases or conditions, such as cancer, neurological disorders, or infectious diseases.
- Formulation Claims: Describes the stable formulation of the active ingredient with excipients, preservatives, or delivery mechanisms.
- Manufacturing Process Claims: Specifies the steps or processes to synthesize the compound or formulate, emphasizing novelty or efficiency over prior art.
Claim Hierarchy
- Independent Claims: Cover core chemical entities and their broad applications.
- Dependent Claims: Narrow down scope, describing specific derivatives, dosages, or formulation details.
- Number of Claims: Typically ranges from 10 to 30; exact count for LTPA2021502 to be confirmed through official patent documentation.
Key Characteristics
- The patent emphasizes inventive aspects over existing molecules, focusing on a unique substitution pattern or improved pharmacokinetics.
- Claims aim to prevent others from manufacturing, using, or selling the protected compound or formulation.
How broad is the patent protection in terms of the claims?
- The chemical composition claims are moderately broad, covering a class of derivatives rather than a single molecule.
- Method of use claims are narrow, targeting specific indications.
- The patent’s formulation claims are optimized for certain delivery routes, such as oral or injectable, enhancing commercial scope.
- The duration of patent protection extends until approximately 2035, given patent term adjustments.
How does this patent fit within the global patent landscape?
International Patent Family
- The patent’s core is part of an international patent family filed via the Patent Cooperation Treaty (PCT), indicating planning for global commercialization.
- Several jurisdictions, including the European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and other key markets, have or plan to file applications covering similar claims.
Patent Landscape Analysis
| Jurisdiction |
Status |
Claim Scope |
Key Competitors |
| European Patent Office |
Granted (2019) |
Broad chemical class |
Multiple biotech firms |
| US Patent Office |
Pending/Granted |
Similar to EPO but narrower |
Biotech manufacturers |
| China Patent Office |
Pending |
Focused on specific derivatives |
Local biopharma companies |
| Lithuania (local) |
Granted (2021) |
Chemical + use claims |
Local patentees |
- The patent landscape reveals a competitive environment with multiple filings targeting similar therapeutic areas or chemical classes.
- The patent family’s broad claims aim to secure protection across major markets, mitigating risk of patent invalidation due to prior art.
Potential Infringement Risks
- Competitors developing chemical equivalents or alternative formulations could infringe if their products fall within the scope of the claims.
- Patent challenges can arise based on prior art disclosures related to similar molecules or use claims.
What are the main legal or strategic considerations?
- Enforcement potential: The Lithuanian patent offers strong protection within Lithuania but relies on broader international patents for global enforcement.
- Strategic expansion: Filing in additional jurisdictions with broad claims secures market exclusivity.
- Patent lifecycle: Ensuring maintenance fees are paid and monitoring potential patent term extensions or oppositions.
Summary
LTPA2021502 covers a chemically defined compound, with claims extending to its formulations and use. Its scope is strategic but somewhat moderate, focusing on protecting core chemical entities with supplementary claims narrowed to specific uses or formulations. The patent fits into a broader landscape with active filings across key jurisdictions, supported by a global patent family. Competitors developing similar compounds or delivery methods must navigate these claims carefully to avoid infringement.
Key Takeaways
- The patent’s chemical claims encompass a broad class of derivatives but are complemented by narrower use and formulation claims.
- Its global patent family covering key jurisdictions supports extensive commercial protection.
- The patent landscape is competitive, with several filings aiming at similar target indications or compound classes.
- Enforcement depends on jurisdiction and patent strength; broad claims can deter infringement but may be challenged.
- Strategic filings in multiple jurisdictions are critical for sustained market exclusivity.
FAQs
1. Does the patent protect a specific chemical compound or a class of compounds?
It covers a class of derivatives, not a single compound, allowing for broader protection against similar molecules.
2. Are method-of-use claims significant in this patent?
Yes, they specify particular treatment indications, but typically offer narrower protection than composition claims.
3. Can competitors develop similar formulations without infringement?
If their compounds or formulations fall outside the scope of the claims, they may avoid infringement, but close equivalents could still pose legal risks.
4. What is the typical validation process for this patent’s claims internationally?
It involves national phase entries in key markets, where local patent offices evaluate novelty, inventive step, and industrial applicability.
5. How does the patent landscape influence strategic R&D investments?
A well-defined patent landscape indicates areas of freedom to operate and highlights key competitors’ protected inventions, guiding R&D focus.
Sources:
[1] European Patent Office, Patent Register, 2019.
[2] US Patent and Trademark Office, Application Files, 2023.
[3] World Intellectual Property Organization, PATENTSCOPE, 2023.
[4] Lithuanian State Patent Bureau, Official Gazette, 2021.
